Depixon 37.5 CR (Paroxetine Prolonged Release 37.5 mg)

Depixon -37.5 CR contains Paroxetine (37.5 mg) in a prolonged-release formulation designed to effectively manage depression anxiety disorders and obsessive-compulsive disorder (OCD). As a selective serotonin reuptake inhibitor (SSRI) Paroxetine helps increase serotonin levels in the brain promoting improved mood and emotional well-being. This formulation provides consistent medication levels making it ideal for individuals seeking long-term management of their mental health conditions.